Arrivent Biopharma, Inc.

AVBP·NASDAQ·$27.94Share Price as of 11/2·$1BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/12/26 10-QQ1 ended 03/31/2605/11/26 10-KFY 202503/05/26 10-QQ3 ended 09/30/2511/10/25 10-QQ2 ended 06/30/2508/11/25

Disclosures

8-KCurrent report10/26/26 8-KCurrent report10/19/26 8-KCurrent report10/13/26 8-KCurrent report10/06/26 8-KCurrent report08/12/26

Prospectuses and Registrations

424B5Prospectus supplement05/11/26 S-8Registration of securities for employees03/05/26 424B5Prospectus supplement07/02/25 424B5Prospectus supplement07/01/25 S-8Registration of securities for employees03/03/25

Proxies

DEF 14ADefinitive proxy04/28/26 DEFA14AAdditional proxy materials04/28/26 DEF 14ADefinitive proxy04/28/25 DEFA14AAdditional proxy materials04/28/25

Ownership

SC 13GBeneficial ownership10/13/26 SC 13D/ABeneficial ownership (amended)10/08/26 Form 4Insider transaction06/22/26 Form 4Insider transaction06/22/26 Form 4Insider transaction06/22/26

Other

ARSAnnual report to shareholders04/28/26 ARSAnnual report to shareholders04/28/25 SEC STAFF LETTERSEC staff letter01/26/24 CERTCEO/CFO certification01/25/24 EFFECTRequest for effectiveness01/25/24